PRECISION BIOSCIENCES INC Contract Liability (Deferred Revenue)
PRECISION BIOSCIENCES INC (DTIL) had Contract Liability (Deferred Revenue) of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-03-12
- 2025-12-31: Contract with Customer, Liability, Current $0.00.
- 2025-09-30: Contract with Customer, Liability, Current $6.25M.
- 2025-06-30: Contract with Customer, Liability, Current $5.99M.
- 2025-03-31: Contract with Customer, Liability, Current $5.73M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $6.25M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $5.99M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $5.73M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.96M 10-K · filed 2026-03-12 |
| 2024-09-30 | $175.00K 10-Q · filed 2024-11-04 |
| 2024-06-30 | $526.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $2.41M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $12.04M 10-K · filed 2025-03-26 |
| 2023-09-30 | $17.45M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $23.81M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $38.27M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $46.19M 10-K · filed 2024-03-27 |
| 2022-09-30 | $48.41M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $41.51M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $19.69M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $21.24M 10-K · filed 2023-03-09 |
| 2021-09-30 | $21.98M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $22.22M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $53.09M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $30.24M 10-K · filed 2022-03-15 |
| 2020-09-30 | $29.22M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $23.06M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $13.31M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $16.49M 10-K · filed 2021-03-18 |
| 2019-09-30 | $10.77M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $7.13M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $9.47M 10-Q · filed 2019-04-29 |
| 2019-01-01 | $8.03M 10-Q · filed 2019-08-14 |
| 2018-12-31 | $8.44M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |